home / stock / fate / fate quote
Last: | $4.5502 |
---|---|
Change Percent: | 0.0% |
Open: | $4.407 |
Close: | $4.55 |
High: | $4.69 |
Low: | $4.28 |
Volume: | 496,411 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.5502 | $4.407 | $4.55 | $4.69 | $4.28 | 496,411 | 07-17-2024 |
$4.55 | $3.92 | $4.55 | $5 | $3.92 | 7,571,205 | 07-16-2024 |
$3.89 | $3.67 | $3.89 | $3.91 | $3.55 | 2,331,612 | 07-15-2024 |
$3.61 | $3.44 | $3.61 | $3.71 | $3.39 | 1,996,053 | 07-12-2024 |
$3.4 | $3.22 | $3.4 | $3.46 | $3.22 | 2,397,454 | 07-11-2024 |
$3.12 | $3.17 | $3.12 | $3.195 | $3.06 | 938,154 | 07-10-2024 |
$3.13 | $3.1 | $3.13 | $3.165 | $3.025 | 1,322,292 | 07-09-2024 |
$3.12 | $3.19 | $3.12 | $3.34 | $3.11 | 983,393 | 07-08-2024 |
$3.17 | $3.17 | $3.17 | $3.17 | $3.09 | 1,168,186 | 07-05-2024 |
$3.16 | $3.21 | $3.16 | $3.355 | $3.14 | 581,507 | 07-04-2024 |
$3.16 | $3.21 | $3.16 | $3.355 | $3.14 | 581,507 | 07-03-2024 |
$3.22 | $3.23 | $3.22 | $3.245 | $3.09 | 1,227,377 | 07-02-2024 |
$3.26 | $3.3 | $3.26 | $3.39 | $3.205 | 1,035,215 | 07-01-2024 |
$3.28 | $3.25 | $3.28 | $3.3 | $3.125 | 3,809,549 | 06-28-2024 |
$3.265 | $3.26 | $3.265 | $3.345 | $3.1 | 1,090,446 | 06-27-2024 |
$3.26 | $3.64 | $3.26 | $3.66 | $3.245 | 1,606,367 | 06-26-2024 |
$3.72 | $3.83 | $3.72 | $3.93 | $3.72 | 802,410 | 06-25-2024 |
$3.84 | $3.76 | $3.84 | $3.98 | $3.76 | 1,298,370 | 06-24-2024 |
$3.76 | $3.65 | $3.76 | $3.81 | $3.61 | 8,303,815 | 06-21-2024 |
$3.59 | $3.41 | $3.59 | $3.67 | $3.3 | 2,557,766 | 06-20-2024 |
News, Short Squeeze, Breakout and More Instantly...
Fate Therapeutics Inc. Company Name:
FATE Stock Symbol:
NASDAQ Market:
Fate Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
2024-06-17 07:30:04 ET Piper Sandler analyst issues OVERWEIGHT recommendation for FATE on June 17, 2024 06:03AM ET. The previous analyst recommendation was Neutral. FATE was trading at $3.61 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellula...